MedPath

上海华源制药安徽广生药业有限公司

Ownership
-
Established
2000-10-25
Employees
-
Market Cap
-
Website
www.hysun-g.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

109

NMPA:109

Drug Approvals

左归丸

Approval Number
国药准字Z20063338
Approval Date
Jan 7, 2021
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H34020239
Approval Date
Jul 9, 2020
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H34020237
Approval Date
Jun 28, 2020
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H34020235
Approval Date
Jun 28, 2020
NMPA

Viamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H34020247
Approval Date
Jun 28, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H34020233
Approval Date
Jun 28, 2020
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H34020240
Approval Date
Jun 28, 2020
NMPA

Viamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H34020243
Approval Date
Jun 28, 2020
NMPA

Viamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H34020248
Approval Date
Jun 28, 2020
NMPA

Viamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H34020244
Approval Date
Jun 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.